Clinical Trials in Phoenix

Showing 3681-3700 of 14,291 trials

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

NCT05580588

Study SPH4336-US-01 is an open-label (no placebo), multicenter clinical trial to evaluate the safety, blood levels (pharmacokinetics) and preliminary anti-tumor effects of SPH4336, a selective enzyme blocker, in patients with specific types of liposarcomas (tumors expressing the target of the study drug).

Liposarcoma, Dedifferentiated

Shanghai Pharma Biotherapeutics USA Inc.14 participantsStarted Aug 2023

Phoenix, Arizona, United States • Duarte, California, United States • Jacksonville, Florida, United States +6 more locations

TERMINATEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

NCT05256134

A study to evaluate the efficacy and safety of gantenerumab in amyloid-positive, cognitively unimpaired participants at risk for or at the earliest stages of AD. The planned number of participants for this study is approximately 1200 participants randomized in a 1:1 ratio to receive either gantenerumab or placebo (600 participants randomized to gantenerumab and 600 participants randomized to placebo).

Alzheimers Disease

Hoffmann-La Roche25 participantsStarted Apr 2022

Phoenix, Arizona, United States • Sun City, Arizona, United States • Tucson, Arizona, United States +60 more locations

Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Find Trials by Condition in Phoenix

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

A Study to Evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

Pioglitazone for the Treatment of Alcohol Use Disorder

Multi-Center Study of ManNAc for GNE Myopathy

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

VB-111 in Surgically Accessible Recurrent/Progressive GBM

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

DETECT-RPC Universal EM Screening

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B